| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol biosynthesis with skeletal dysplasias 0.8762267572592212 3.14883106772768 0.0016392492635759 0.615751760607232 0.2771489317414449 7 O75845,Q16850,Q9UBM7,Q15125,Q15392 5 |
| Sphingolipid metabolism in senescence 0.8855153926220566 3.122741776353988 0.0017917487323824 0.6484932805054552 0.2771489317414449 10 Q96G23,P04062,Q13510,Q16739,Q06136,O15121,P16278 7 |
| Mthfr deficiency 0.8401729986505801 3.0147384843207594 0.0025720091792995 0.7771849010823735 0.2771489317414449 6 P49419,P21964,P35790 3 |
| Sphingolipid metabolism integrated pathway 0.8432255947492638 2.9832226024204433 0.0028523046148347 0.8108603502534278 0.2771489317414449 8 O95470,Q96G23,Q13510,Q16739,Q06136,O15121 6 |
| Sphingolipid metabolism overview 0.8432255947492638 2.9832226024204433 0.0028523046148347 0.8108603502534278 0.2771489317414449 8 O95470,Q96G23,Q13510,Q16739,Q06136,O15121 6 |
| Sphingolipid pathway 0.8366876141990203 2.9321894036368463 0.0033658140644534 0.8599252885682838 0.2803242285109101 9 O95470,Q96G23,P04062,Q13510,Q16739,Q06136 6 |
| Glycosaminoglycan degradation 0.7789384741179273 2.741054947644256 0.0061242264867602 0.9721633540910372 0.3967137824201365 6 P54802,P06865,P16278 3 |
| 7oxoc and 7betahc pathways 0.7815481757412941 2.6846661735185773 0.0072602281862474 0.9857093962941132 0.4055489116606727 9 O15118,Q15125,O14734,P61916 4 |
| Glycerophospholipid biosynthetic pathway 0.7559940937262397 2.6127088785671253 0.0089827782293476 0.994807929622401 0.4055489116606727 7 Q9HCL2,P48651,O00116,Q9BTU6 4 |
| Degradation pathway of sphingolipids including diseases 0.7409744128986888 2.56599480555072 0.010288036884807 0.997592080551806 0.4055489116606727 6 P17900,P07686,P06865,P06280,P16278 5 |
| Ethanol effects on histone modifications 0.7400311506376939 2.5154506967283323 0.011888030341312 0.9990624565347028 0.4331701055615571 8 Q99707,O14929,P00374 3 |
| Allograft rejection 0.7167794270797082 2.382814458110083 0.0171808513103866 0.9999590631612806 0.4431859811953104 9 P08670,Q9BY49,P08183,P10321,P04439 5 |
| Oxysterols derived from cholesterol 0.7027296619411508 2.361913770486108 0.0181808705072621 0.9999773869891992 0.4431859811953104 7 Q15125,O14734 2 |
| Familial partial lipodystrophy fpld 0.617566938305859 1.9426112495447352 0.0520631466546528 0.999999999999971 0.5439500967976231 7 O60725 1 |
| Nrf2are regulation 0.6115073901557829 1.9119023877160384 0.055888715379575 0.9999999999999972 0.5439500967976231 7 P09601 1 |
| Camkk2 pathway 0.6185178822825341 1.8773675829197325 0.0604677313003461 1.0 0.5439500967976231 10 P09601,Q14012 2 |
| Influence of laminopathies on wnt signaling 0.620768001579027 1.8657298432740548 0.062079172143808 1.0 0.5439500967976231 11 O60725,O75844 2 |
| Vitamin d receptor pathway 0.615339747366595 1.8612648383647776 0.0627067860162042 1.0 0.5439500967976231 10 P08183,Q5VV42,Q96KA5 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.8286514672556697 1.7939958163916867 0.0728138365890578 1.0 0.5815132428961741 5 Q16739,Q06136,O95470 3 |
| Disorders of folate metabolism and transport 0.5907480303440729 1.7822612183329067 0.074706643820658 1.0 0.5822002295291383 8 P00374 1 |
| Vitamin b12 metabolism 0.5813468925338137 1.781093890981388 0.0748971135757896 1.0 0.5822002295291383 6 Q8WTV0 1 |
| Cytosolic dnasensing pathway 0.5820967323583021 1.7142570994070063 0.0864815183512817 1.0 0.6382117113771801 9 Q9BUI4 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5965693669338097 1.6743276919238133 0.0940662150229427 1.0 0.6528643256949479 14 O75844,O60725,P48729,P50402,P42166,P55209 6 |
| Glycosylation and related congenital defects 0.5553068344113735 1.5747495041853758 0.1153142761686174 1.0 0.7072464027128582 9 Q2TAA5,Q13724,Q9BT22 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7665992822228428 1.5320206113937642 0.1255173485865237 1.0 0.7072464027128582 5 P09601 1 |
| Progeriaassociated lipodystrophy 0.5430062248234921 1.4868715518088456 0.137048739104924 1.0 0.7345104449481619 10 O60725 1 |
| Triacylglyceride synthesis 0.7474663385809694 1.450304296736078 0.1469736814059303 1.0 0.7345104449481619 5 Q9HCL2,O00116 2 |
| Mitochondrial complex iii assembly 0.5262050527308945 1.3750259854472426 0.1691233887205012 1.0 0.7667033980313881 11 O14949,P22695,Q6DKK2 3 |
| Ferroptosis 0.5530294622974861 1.3173444836669583 0.187723180746743 1.0 0.8099648345666141 20 P37268,P16435,P08195,Q9Y277,Q9UKU0,P02786,P45880,Q9NZ45,P09601,P48507 10 |
| Metapathway biotransformation phase i and ii 0.548338767517669 1.2929007600503526 0.1960453846149177 1.0 0.8099648345666141 20 Q16850,Q8NCH0,P21964,Q99735,Q7LGA3,P07099 6 |
| Cholesterol biosynthesis pathway 0.5091867334442666 1.2618215364390897 0.2070130108090051 1.0 0.8266341459017124 12 O75845,Q16850,P37268,Q15800,Q9UBM7,P48449 6 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5401264107517642 1.2078142393324562 0.227118723068826 1.0 0.8316737171496873 22 O75845,Q16850,P35610,P37268,Q15800,Q9UBM7,P14324,Q14534,P48449,Q15125,Q15392,Q14739 12 |
| P53 transcriptional gene network 0.4805013184408354 1.1988915284500616 0.2305701262346737 1.0 0.8316737171496873 8 Q7LG56,P04066 2 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4716040311201041 1.1970409518800127 0.2312905932845987 1.0 0.8316737171496873 6 Q15418 1 |
| 3q29 copy number variation syndrome 0.4829176453677483 1.1889901539207377 0.2344435414720584 1.0 0.8334181992573786 9 O95684,Q8NCM8,O75592 3 |
| Oxidation by cytochrome p450 0.685753406804914 1.1849044919521814 0.2360552111711691 1.0 0.8340617461381309 5 Q16850,O43169 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4745735554577288 1.1668016394563376 0.2432904847897703 1.0 0.8516877724110534 8 Q8TB36,Q9NR77 2 |
| Proteoglycan biosynthesis 0.9129328899028686 1.1374758030630707 0.2553394342923378 1.0 0.8654819197234476 4 Q8TB61,Q8NCH0 2 |
| Ketogenesis and ketolysis 0.6684062716500409 1.1101372282231294 0.2669398971077892 1.0 0.8743031461451748 5 P53985,P23786,O43772 3 |
| Mitochondrial complex iv assembly 0.4802964046332778 1.0851840769194698 0.2778401351370982 1.0 0.8810281419559275 13 Q7KZN9,P14406,Q9P0S2,Q9Y2R0,P00403,Q9BSH4 6 |
| Folate metabolism 0.4799619799945256 1.083395110089849 0.2786330852033789 1.0 0.8810281419559275 13 Q8WTV0,P00374 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4546050231184834 1.081282347352983 0.2795715373273526 1.0 0.8810281419559275 7 P31943 1 |
| Selenium micronutrient network 0.4549269064428903 1.037607104888668 0.2994530088064782 1.0 0.8932667869934582 9 Q8WTV0 1 |
| Vitamin d metabolism 0.8949579831932777 1.0150263288585883 0.3100932771567306 1.0 0.8932667869934582 3 P38435,P04062 2 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.6442139887572652 1.0060944001942735 0.3143701621536934 1.0 0.8932667869934582 5 Q7Z434 1 |
| Tyrobp causal network in microglia 0.4353698599822897 0.9991914845769994 0.3177019401638561 1.0 0.894783725195788 6 P61916 1 |
| Fluoropyrimidine activity 0.4571948001496101 0.9833300582111362 0.3254450210319577 1.0 0.8971358124836969 12 Q92820,P18074,P00374 3 |
| Kennedy pathway from sphingolipids 0.8542907180385301 0.9310941599907284 0.3518048592657186 1.0 0.92670956662847 4 Q9UG56,O95470,P35790 3 |
| Nucleotide metabolism 0.4535578652868719 0.9207060254992968 0.3572039294752367 1.0 0.92670956662847 14 P00374 1 |
| Praderwilli and angelman syndrome 0.6215327240187756 0.9090953374596592 0.3632998035439725 1.0 0.92670956662847 5 Q7L576,Q15154 2 |
| Copper homeostasis 0.6208539641412224 0.9062045571625456 0.3648275913905918 1.0 0.92670956662847 5 O75880,Q04656,P05067 3 |
| Nephrotic syndrome 0.4395569234635983 0.8888353054585242 0.3740915985055701 1.0 0.9302274234556024 12 Q14108 1 |
| Disruption of postsynaptic signaling by cnv 0.414867437352729 0.8872152442957656 0.3749630266073183 1.0 0.9302274234556024 6 Q7L576 1 |
| Eicosanoid synthesis 0.8211410570528523 0.8717966358333612 0.3833193302088287 1.0 0.9306802230262368 2 P09960 1 |
| Genes related to primary cilium development based on crispr 0.42421475287596 0.8714945257978802 0.3834841935580249 1.0 0.9306802230262368 9 Q10713,O95684,Q9Y496,Q8NCM8 4 |
| P38 mapk signaling pathway 0.408692604276198 0.8535853496715916 0.3933347787907817 1.0 0.9306802230262368 6 P42224,P60953,P62993,P04792,Q13546 5 |
| Statin inhibition of cholesterol production 0.8318739054290738 0.8534417482192559 0.3934143782841672 1.0 0.9306802230262368 4 Q14534,P37268,Q8WTV0 3 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.829068195743534 0.8437905313664609 0.3987864675264227 1.0 0.9326732339425954 4 P09601 1 |
| Ciliopathies 0.4323372862899062 0.8290659035451279 0.4070671161879748 1.0 0.9326732339425954 13 Q15555,Q8NCM8,O43924,Q9UBB4,Q99570,Q10713 6 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.837822057440403 0.8044395844347639 0.4211431478094749 1.0 0.941397444495292 3 P09601 1 |
| Adipogenesis 0.4210680955864255 0.7903018749993204 0.4293514920685846 1.0 0.941628424678654 12 P43490,O75844 2 |
| Urea cycle and related diseases 0.7987399369968498 0.7815595060089193 0.4344734926904938 1.0 0.941628424678654 2 Q9Y619 1 |
| Amyotrophic lateral sclerosis als 0.4007283228180465 0.766818969057959 0.4431891565178101 1.0 0.9439549643911704 8 O96008,Q9BUN8 2 |
| Transsulfuration pathway 0.3904713228384566 0.7332836234048317 0.4633854612390773 1.0 0.9573324656201718 7 Q99707 1 |
| Glycerolipids and glycerophospholipids 0.7908004188529125 0.7140556724738935 0.4751927546760652 1.0 0.9573324656201718 4 Q9HCL2,Q9UG56 2 |
| Complement system in neuronal development and plasticity 0.38888880878133 0.7035827971703403 0.4816926276213835 1.0 0.9573324656201718 8 Q5KU26 1 |
| Nanomaterial induced apoptosis 0.8067539001029969 0.6940955402664724 0.4876222952146447 1.0 0.9573324656201718 3 O95831 1 |
| Ccl18 signaling pathway 0.3824435141599115 0.6487066501745353 0.5165280051317105 1.0 0.9908708395474528 9 P00403,P08670,Q86UE4 3 |
| Spinal cord injury 0.3994481026547536 0.6362181197575242 0.5246342645389821 1.0 0.9914347715590704 14 P08670,P11802,Q9NQC3,P06493,Q08722 5 |
| Methionine de novo and salvage pathway 0.3837776201455216 0.6352488442276423 0.525266131590189 1.0 0.9914347715590704 10 Q13126 1 |
| Zinc homeostasis 0.7539376968848441 0.609134862046035 0.5424350515229022 1.0 1.0 2 Q8TAD4 1 |
| Reninangiotensinaldosterone system raas 0.7755602240896367 0.5875170802247768 0.5568564826202258 1.0 1.0 3 Q14012,P0DP25 2 |
| Il10 antiinflammatory signaling pathway 0.7382675486755588 0.5437903909371505 0.5865857219734458 1.0 1.0 4 P09601 1 |
| Intraflagellar transport proteins binding to dynein 0.3511194158266744 0.5265182644223899 0.5985281652652583 1.0 1.0 7 O43237,Q8NCM8 2 |
| Wnt signaling 0.3685116760551204 0.517649072810478 0.6047031365944391 1.0 1.0 12 P67870,P48729,Q8TAA9 3 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3578306446147077 0.4832354200601506 0.6289285883808082 1.0 1.0 11 P13674,Q32P28,O75718,P07237 4 |
| Tryptophan metabolism 0.3645468685676655 0.4607124780032939 0.6450049014624417 1.0 1.0 14 Q15392 1 |
| Nrf2 pathway 0.3847164720044242 0.433397226531186 0.664726215073888 1.0 1.0 21 P09601,Q14914 2 |
| Onecarbon metabolism 0.3611050107193652 0.4260653804006651 0.6700602056996199 1.0 1.0 15 P00374 1 |
| Mitochondrial immune response to sarscov2 0.3255626121210491 0.3631518973256717 0.7164914185390403 1.0 1.0 9 Q7Z434 1 |
| Vasopressinregulated water reabsorption 0.3445968845666634 0.3486342288908274 0.7273639272002335 1.0 1.0 15 Q8NCM8,Q13561,Q9UJW0,O43237,Q14203,Q9Y6G9,P61020 7 |
| Mecp2 and associated rett syndrome 0.351585790669905 0.3307818367916167 0.7408092814441527 1.0 1.0 18 P52597,P31943,P35637,P67809,Q99640 5 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3787039651529226 0.323980395781305 0.7459528763437913 1.0 1.0 26 Q16850,P37268,Q8WTV0,Q9NR31,Q9UKV5,Q9HCL2,P48449,O95487 8 |
| Thermogenesis 0.3662102345830718 0.315929231879978 0.7520562235713486 1.0 1.0 23 O43772,P23786,Q15418 3 |
| 15q112 copy number variation syndrome 0.6590854791974325 0.3141408429130747 0.7534140703390513 1.0 1.0 4 Q96CW5,Q9BSJ2 2 |
| 16p112 distal deletion syndrome 0.470567624386818 0.3140301178375596 0.7534981642476768 1.0 1.0 5 Q8WWM7,Q99873,P49411,P62993 4 |
| Iron metabolism in placenta 0.6513825691284565 0.2776883537596032 0.781251601484501 1.0 1.0 2 P02786 1 |
| Wntbetacatenin signaling pathway in leukemia 0.6368810541535743 0.2577495976801109 0.7966001655645616 1.0 1.0 4 P48729 1 |
| Tnfalpha signaling pathway 0.3220815752461351 0.2492351185837667 0.8031789156480824 1.0 1.0 15 Q9NR28,P68400,P53350,Q13616,P07900,Q13200,P62993,Q16543,Q15750,P06737,P27361,P63000,P63208,Q13546 14 |
| Phosphoinositides metabolism 0.2860147213459506 0.2347775903311424 0.8143813619662437 1.0 1.0 6 Q9NTJ5,P19174,Q01968,Q9Y217,Q99570 5 |
| Joubert syndrome 0.3174405777177624 0.2297946880188716 0.8182513126289384 1.0 1.0 15 O43924 1 |
| Apoptosis modulation and signaling 0.2941126517544916 0.2078384875854024 0.8353550799903164 1.0 1.0 10 O95831 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6408328767652574 0.2054054405090163 0.8372553699900083 1.0 1.0 3 P48729 1 |
| Osteoblast differentiation and related diseases 0.2862153630305102 0.2051173598205691 0.8374804336131969 1.0 1.0 8 Q05655,P42224,Q04721,P35222,Q99570,P78527,P27361 7 |
| Transsulfuration and onecarbon metabolism 0.315586037159694 0.1933479888179847 0.8466864456669394 1.0 1.0 17 P00374 1 |
| Proximal tubule transport 0.2896653778389855 0.1898281503305278 0.8494437961815375 1.0 1.0 10 P05023,P08183 2 |
| Osx and mirnas in tooth development 0.6139306965348266 0.1872879237238946 0.851434890932625 1.0 1.0 2 Q04721 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.306547598763103 0.1857626575953016 0.8526308896907275 1.0 1.0 15 P50416,P49748,O43772,P23786,P16219 5 |
| Hedgehog signaling pathway wp4249 0.6237869392087578 0.1693225159138387 0.8655429665417722 1.0 1.0 3 Q9Y496 1 |
| G1 to s cell cycle control 0.3304316159588593 0.155866436724555 0.8761383015301465 1.0 1.0 24 Q14566,P35244,P11802,P49736,P33993,P06493,Q9Y619,Q99640 8 |
| Estrogen receptor pathway 0.6110289074176274 0.1444490538041301 0.8851458836074262 1.0 1.0 3 Q9HCL2 1 |
| Rala downstream regulated genes 0.4085494043447751 0.1281337402450136 0.8980431352625282 1.0 1.0 5 P60953,P16989,P11233,Q96KP1 4 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.4085494043447726 0.1281337402450074 0.8980431352625331 1.0 1.0 5 P35222,P27361,P49841,Q13546 4 |
| Mitochondrial complex i assembly model oxphos system 0.3376882890045465 0.1078746778215575 0.9140951040545292 1.0 1.0 30 Q7L592,Q96CU9,O43676,P03886,O75438,O75306,O95168,Q9P0J0,Q9BUB7 9 |
| Type ii diabetes mellitus 0.5624781239061952 0.0947288523116 0.9245302001917556 1.0 1.0 2 P42345 1 |
| Glutathione metabolism 0.2474292722057117 0.0866198472155908 0.9309736893979674 1.0 1.0 6 P48507 1 |
| Interactions between loxl4 and oxidative stress pathway 0.5679271708683489 0.0741860638918653 0.9408623346963364 1.0 1.0 3 Q9BQ95,Q16543 2 |
| Biomarkers for pyrimidine metabolism disorders 0.2450145521686081 0.0559774780821389 0.955359748909946 1.0 1.0 8 Q7LG56 1 |
| Heme biosynthesis 0.5280579973144647 0.0487469275142419 0.9611209775559604 1.0 1.0 4 P22830 1 |
| Network map of sarscov2 signaling pathway 0.2872436542437359 0.0354186131424711 0.9717459428816262 1.0 1.0 22 P31350,Q96J02,P06493,Q9UBR2,Q7Z434,Q08380 6 |
| Pyrimidine metabolism and related diseases 0.2333506734913361 0.021891028487065 0.9825348812918868 1.0 1.0 8 Q7LG56 1 |
| Heart development 0.481274063703185 0.0172397365086634 0.9862453617434042 1.0 1.0 2 P35222 1 |
| Pilocytic astrocytoma 0.4812740637031849 0.0172397365086631 0.9862453617434044 1.0 1.0 2 P62993 1 |
| Steroid biosynthesis 0.4735736786839341 0.0133529072253031 0.9893462380785634 1.0 1.0 2 Q99829 1 |
| Signal transduction through il1r 0.4560728036401817 0.0061541426585782 0.9950897355825552 1.0 1.0 2 Q9BQ95 1 |
|
|
